Health News

Latest results from UK study show public attitudes towards mental illness are moving in the right direction

Date: Nov-14-2013
Public attitudes and intended behaviour related to mental illness are improving but there is still more work to be done according to a new report commissioned by the anti-stigma programme Time to Change and published by the charities behind the campaign, Mind and Rethink Mental Illness. The research, which is funded by the Department of Health and conducted by TNS, brings together nearly two decades worth of data (1994 to 2012) looking into the adult population's (16+) perceptions of people who experience mental health problems.

Neuroptis Biotech announces the preclinical results for its dry eye product ML7

Date: Nov-14-2013
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye. The candidate molecule, ML7, is the first in a new therapeutic class. It has the potential to bring an effective, targeted therapeutic response to the millions of people who suffer from dry eye syndromes.

New study shows benefits to patients from receiving treatment at hospitals that actively carry out research

Date: Nov-14-2013
A widely held assumption that patients benefit from receiving treatment in hospitals active in research has been demonstrated by a new study.Researchers from the Faculty of Health, Social and Education at Kingston University and St George's, University of London working with partners at the Health Economics Research Group at Brunel University, London, looked at research papers in a diverse range of areas such as breast cancer treatment and the rehabilitation of veterans with war injuries.

Sanford-Burnham receives U.S. Air Force grant to perform next-generation toxicity screens

Date: Nov-14-2013
A bicoastal group of scientists at Sanford-Burnham Medical Research Institute (Sanford- Burnham) was recently awarded a three - year grant from the U.S. Department of the Air Force to assess the potential toxicity of large collections of chemicals. The goal of the project is to provide an early and relevant assessment of potential toxicities in a rapid, cost effective manner."The current approach to assessing the health risks of chemical exposure relies extensively on data from animal models. But humans may react very differently to chemicals than animals," said Anne Bang, Ph.D.

Primary care key to management of patients with HIV infection

Date: Nov-14-2013
The HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis. "In many HIV practices now, 80 percent of patients with HIV infection have the virus under control and live long, full lives.

New research defines the cardiovascular risk factors associated with chronic kidney disease

Date: Nov-14-2013
New research presented at the Euro-Chapter of the International Union of Angiology has identified the potential for screening early risk factors of chronic kidney disease1 (CKD). There are an estimated 45,000 premature deaths annually associated with the disease2. The research, a collaboration between Imperial College London and Life Line Screening, collected data from nearly 3,000 Irish and British individuals who had self-selected for cardiovascular check-ups.

UCLA nanotechnology researchers prove two-step method for potential pancreatic cancer treatment

Date: Nov-14-2013
A new method of microscopic drug delivery that could greatly improve the treatment of deadly pancreatic cancer has been proven to work in mice at UCLA's Jonsson Comprehensive Cancer Center.The research team led by Drs. Andre Nel, professor of nanomedicine and member of the California Nanosystems Institute (CNSI), and Huan Meng, adjunct assistant professor of nanomedicine, published the results of their study in the journal ACS Nano online ahead of print and featured in the November 2013 print issue.

Tailored pre-transplant therapy boosts survival rate in rare immune deficiency

Date: Nov-14-2013
Chronic Granulomatous Disease is a rare immune deficiency that seriously compromises organ function and is life-threatening, with 20-30 per cent of patients dying within the first two decades of life. Cell transplantation, the only cure available to date, requires chemotherapy prior to transplantation in order to avoid transplant rejection, although there is a risk of complications such as central nervous system damage, organ failure, and infertility.

Global Coalition Against Child Pneumonia calls for continued investment in innovations and proven tools

Date: Nov-14-2013
Fifth Annual World Pneumonia Day marks successes and challenges in tackling #1 killer of childrenGlobal health advocates commemorated the fifth annual World Pneumonia Day by calling on global leaders to scale up existing interventions and invest in new diagnostics and treatments to defeat pneumonia. Each year, pneumonia kills more children than AIDS, malaria and tuberculosis combined. Pneumonia took the lives of nearly 1.

Detecting breast-cancer related lymphedema - a new solution

Date: Nov-14-2013
Findings suggest affective reliable and accurate measurement of Lymphedema may help ease breast-cancer survivors fearsViewed as one of the most feared outcomes of breast cancer treatment, doctors struggle detecting and diagnosing breast-cancer related Lymphedema - a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.Now, a team of researchers led by Mei R.